The following is a summary of "Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and ...

Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...

People who regularly engage in significant amounts of exercise, as endurance athletes do, may develop enlarged hearts. While ...

People with a complex heart, kidney and metabolic-related condition who got better quality sleep were less likely to have an ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...

From heart rate and wrist temperature (available on Apple Watch Series 8 or later and any Apple Watch Ultra model) to ...

The following is a summary of "Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients ...

Atrial fibrillation burden decreased progressively ... different between the treatment and control groups. The duration of automatic mode switching was similar in the control and treatment groups ...

Kezar Life Sciences (KZR) reported topline results from the PORTOLA Phase 2a clinical trial evaluating zetomipzomib, a selective ...